{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:41:02Z","timestamp":1762540862922,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82151314","82101623","82171544","82371505","82101582"],"award-info":[{"award-number":["82151314","82101623","82171544","82371505","82101582"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2023YFC2506800"],"award-info":[{"award-number":["2023YFC2506800"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202440203"],"award-info":[{"award-number":["202440203"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.schres.2025.09.024","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:30:00Z","timestamp":1759339800000},"page":"196-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Two-month antipsychotic exposure induces domain-specific eye movement alterations in clinical high-risk individuals"],"prefix":"10.1016","volume":"285","author":[{"given":"Aimei","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiru","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wensi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawen","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.schres.2025.09.024_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0269881119889296","article-title":"Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology","volume":"34","author":"Barnes","year":"2020","journal-title":"J. Psychopharmacol. (Oxf. Engl.)"},{"issue":"1","key":"10.1016\/j.schres.2025.09.024_bb0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/WNO.0000000000001452","article-title":"Temporal patterns of spontaneous fixational eye movements: the influence of basal ganglia","volume":"42","author":"Beylergil","year":"2022","journal-title":"J. Neuroophthalmol."},{"issue":"11","key":"10.1016\/j.schres.2025.09.024_bb0015","article-title":"Interventions for prodromal stage of psychosis","volume":"2019","author":"Bosnjak Kuharic","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.schres.2025.09.024_bb8000","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0006-3223(92)90178-3","article-title":"SPEM impairment in drug-naive schizophrenic patients: evidence for a trait marker","volume":"32","author":"Campion","year":"1992","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2025.09.024_bb0020","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/appi.ajp.158.5.765","article-title":"A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder","volume":"158","author":"Conley","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2025.09.024_bb0025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/wps.20526","article-title":"Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis","volume":"17","author":"Davies","year":"2018","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2025.09.024_bb0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neubiorev.2021.06.020","article-title":"Functional brain network dysfunctions in subjects at high-risk for psychosis: a meta-analysis of resting-state functional connectivity","volume":"128","author":"Del Fabro","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.schres.2025.09.024_bb0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s004060200011","article-title":"Smooth pursuit eye movements of patients with schizophrenia and affective disorder during clinical treatment","volume":"252","author":"Flechtner","year":"2002","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2025.09.024_bb0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0165-1781(92)90015-U","article-title":"Effect of typical antipsychotic medications and clozapine on smooth pursuit performance in patients with schizophrenia","volume":"41","author":"Friedman","year":"1992","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2025.09.024_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00764","article-title":"Preventive treatments for psychosis: umbrella review (just the evidence)","volume":"10","author":"Fusar-Poli","year":"2019","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2025.09.024_bb0050","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0004867416641195","article-title":"Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders","volume":"50","author":"Galletly","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2025.09.024_bb0055","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/S0033291705006756","article-title":"Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia","volume":"36","author":"Harris","year":"2006","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.schres.2025.09.024_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.bp.113.138578","article-title":"A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic)","volume":"205","author":"Howes","year":"2014","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"issue":"3","key":"10.1016\/j.schres.2025.09.024_bb0065","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1017\/S0033291798006722","article-title":"Smooth pursuit and saccadic abnormalities in first-episode schizophrenia","volume":"28","author":"Hutton","year":"1998","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.schres.2025.09.024_bb0070","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41598-017-01076-w","article-title":"Switch from ambient to focal processing mode explains the dynamics of free viewing eye movements","volume":"7","author":"Ito","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.schres.2025.09.024_bb0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/jamapsychiatry.2020.3604","article-title":"Multimodal machine learning workflows for prediction of psychosis in patients with clinical high-risk syndromes and recent-onset depression","volume":"78","author":"Koutsouleris","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2025.09.024_bb0080","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1001\/archpsyc.65.10.1146","article-title":"Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia","volume":"65","author":"Lencer","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2025.09.024_bb0085","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/schbul\/sbv037","article-title":"Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method","volume":"41","author":"Leucht","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.schres.2025.09.024_bb0090","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00023210-200418040-00005","article-title":"Dopamine partial agonists: a new class of antipsychotic","volume":"18","author":"Lieberman","year":"2004","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.schres.2025.09.024_bb0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0920-9964(94)90068-X","article-title":"Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophrenia","volume":"12","author":"Litman","year":"1994","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2025.09.024_bb0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrn3405","article-title":"The impact of microsaccades on vision: towards a unified theory of saccadic function","volume":"14","author":"Martinez-Conde","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2025.09.024_bb0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1469-8986.1996.tb02112.x","article-title":"Timing and amplitude of saccades during predictive saccadic tracking in schizophrenia","volume":"33","author":"McDowell","year":"1996","journal-title":"Psychophysiology"},{"issue":"5","key":"10.1016\/j.schres.2025.09.024_bb0110","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1176\/ajp.2006.163.5.790","article-title":"Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis","volume":"163","author":"McGlashan","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2025.09.024_bb0115","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1176\/appi.ajp.159.5.863","article-title":"Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity","volume":"159","author":"Miller","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2025.09.024_bb0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s004060050059","article-title":"Internally and externally guided voluntary saccades in unmedicated and medicated schizophrenic patients. Part II. Saccadic latency, gain, and fixation suppression errors","volume":"249","author":"M\u00fcller","year":"1999","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.schres.2025.09.024_bb0125","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nrn1345","article-title":"Look away: the anti-saccade task and the voluntary control of eye movement","volume":"5","author":"Munoz","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"8","key":"10.1016\/j.schres.2025.09.024_bb0130","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00213-016-4234-9","article-title":"An investigation into aripiprazole's partial D\u2082 agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteers","volume":"233","author":"Murphy","year":"2016","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.schres.2025.09.024_bb0135","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1038\/s41380-022-01611-w","article-title":"Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: a systematic review and meta-analysis","volume":"27","author":"Oliver","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2025.09.024_bb0140","article-title":"Visual fixation durations and saccade amplitudes: shifting relationship in a variety of conditions","volume":"2","author":"Pannasch","year":"2008","journal-title":"J.o.E.M.R."},{"key":"10.1016\/j.schres.2025.09.024_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104142","article-title":"Clinical High-Risk for Psychosis (CHR-P) circa 2024: synoptic analysis and synthesis of contemporary treatment guidelines","volume":"100","author":"Poletti","year":"2024","journal-title":"Asian J. Psychiatr."},{"issue":"2","key":"10.1016\/j.schres.2025.09.024_bb0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biopsych.2004.10.024","article-title":"Abnormalities in visually guided saccades suggest corticofugal dysregulation in never-treated schizophrenia","volume":"57","author":"Reilly","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2025.09.024_bb0155","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.biopsych.2006.10.031","article-title":"Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia","volume":"62","author":"Reilly","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2025.09.024_bb0160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bandc.2008.08.026","article-title":"Pharmacological treatment effects on eye movement control","volume":"68","author":"Reilly","year":"2008","journal-title":"Brain Cogn."},{"issue":"3","key":"10.1016\/j.schres.2025.09.024_bb0165","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.eurpsy.2015.01.013","article-title":"EPA guidance on the early intervention in clinical high risk states of psychoses","volume":"30","author":"Schmidt","year":"2015","journal-title":"Eur. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2025.09.024_bb0170","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0165-6147(94)90323-9","article-title":"Dopamine receptor pharmacology","volume":"15","author":"Seeman","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"issue":"Suppl. 20","key":"10.1016\/j.schres.2025.09.024_bb0175","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2025.09.024_bb0180","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1038\/s41380-023-02203-y","article-title":"Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis","volume":"28","author":"Siafis","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2025.09.024_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004060050058","article-title":"Internally and externally guided voluntary saccades in unmedicated and medicated schizophrenic patients. Part I. Saccadic velocity","volume":"249","author":"Straube","year":"1999","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.schres.2025.09.024_bb9000","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0006-3223(99)00132-8","article-title":"Pursuit tracking impairments in schizophrenia and mood disorders: step-ramp studies with unmedicated patients","volume":"46","author":"Sweeney","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2025.09.024_bb0190","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0006-3223(98)00035-3","article-title":"Eye tracking abnormalities in schizophrenia: evidence for dysfunction in the frontal eye fields","volume":"44","author":"Sweeney","year":"1998","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2025.09.024_bb0195","first-page":"166","article-title":"Neuroimaging markers of resiliency in youth at clinical high risk for psychosis: a qualitative review","volume":"6","author":"Vargas","year":"2021","journal-title":"Biol. Psychiatry: Cognit. Neurosci. Neuroimaging"},{"issue":"1","key":"10.1016\/j.schres.2025.09.024_bb0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00213-013-3091-z","article-title":"Effects of amisulpride on human resting cerebral perfusion","volume":"229","author":"Viviani","year":"2013","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.schres.2025.09.024_bb0205","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4088\/JCP.08m04979ora","article-title":"Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis","volume":"72","author":"Yung","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2025.09.024_bb0210","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3758\/s13428-017-0860-3","article-title":"Using machine learning to detect events in eye-tracking data","volume":"50","author":"Zemblys","year":"2018","journal-title":"Behav. Res. Methods"},{"issue":"3","key":"10.1016\/j.schres.2025.09.024_bb0215","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00406-022-01463-z","article-title":"Eye movement indices as predictors of conversion to psychosis in individuals at clinical high risk","volume":"273","author":"Zhang","year":"2023","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.schres.2025.09.024_bb0220","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/schbul\/sbae001","article-title":"Eye movement characteristics for predicting a transition to psychosis: longitudinal changes and implications","volume":"51","author":"Zhang","year":"2025","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.schres.2025.09.024_bb0225","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1177\/0004867420917449","article-title":"Real-world effectiveness of antipsychotic treatment in psychosis prevention in a 3-year cohort of 517 individuals at clinical high risk from the SHARP (ShangHai At Risk for Psychosis)","volume":"54","author":"Zhang","year":"2020","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2025.09.024_bb0230","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/0004867420969810","article-title":"When to initiate antipsychotic treatment for psychotic symptoms: at the premorbid phase or first episode of psychosis?","volume":"55","author":"Zhang","year":"2021","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2025.09.024_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2025.01.021","article-title":"Two-month cognitive changes enhance prediction of nonremission in clinical high-risk individuals","author":"Zhang","year":"2025","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2025.09.024_bb0240","first-page":"175","article-title":"The effects of antipsychotics on two month cortical thickness and two year clinical outcomes among populations at clinical high risk for psychosis","volume":"98","author":"Zheng","year":"2025","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.schres.2025.09.024_bb0245","article-title":"Wearable near-eye tracking technologies for health: a review","volume":"11","author":"Zhu","year":"2024"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996425003342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996425003342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:28:01Z","timestamp":1762540081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996425003342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":51,"alternative-id":["S0920996425003342"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2025.09.024","relation":{},"ISSN":["0920-9964"],"issn-type":[{"type":"print","value":"0920-9964"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two-month antipsychotic exposure induces domain-specific eye movement alterations in clinical high-risk individuals","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2025.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}